Komori
Shimadzu (7701) · InitiativeAdvanced

Expanding sales of X-ray products for the clinic market through rapid compliance with standards

First written in FY2017-Q2. 7 of 19 entries say "Reframed", first in FY2018-Q1. Latest entry: 2026-10-13.

19entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q2 – FY2019-Q3AdvancedFY2021 – FY20232016: 12017: 320172018: 220182019: 320192020: 420202021: 220212022: 020222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Establishing Medical-Equipment Production Capabilities and Expanding OrdersA theme 13 companies write about · 0 as a headwind · 14 as a tailwind

The whole theme swung hardest in 2024: 2 of 7 companies on the "Worse" side.

5 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-13Advancedfinance.yahoo.co.jp

    「Revenue in the Medical Equipment segment increased 23% year on year to ¥16.9 billion, driven by the effect of new X-ray products. As the company also reduced its handling of less profitable products, the segment swung to an ¥1.1 billion profit from a loss in the same period of the previous year.」

    The Medical Equipment segment's revenue growth and return to profitability were reported, driven by the effect of new X-ray products and reduced handling of unprofitable products.
  2. FY2026-H1AdvancedAnnual report

    「The medical systems business performed well, with strong sales of X-ray TV systems equipped with new software to improve patient safety, but overall revenue declined due to weak market conditions in Japan, Europe and China.」

    The expansion of sales of X-ray-related products was supported by the strong performance of X-ray TV systems equipped with new software that improves patient safety.
  3. FY2025-H1ReframedAnnual report

    「Meanwhile, X-ray TV system sales in North America increased as hospitals' operating environment recovered, while angiography system sales increased in other parts of Asia, including the Philippines, as technical exchange meetings raised awareness.」

    The drivers of expanded sales of X-ray-related products have broadened beyond compliance with existing standards and the clinic market to include the recovery of the hospital operating environment in North America and greater awareness generated by technical exchange meetings in the Philippines and elsewhere.
  4. FY2023AdvancedAnnual report

    「The recovery in capital investment by medical institutions contributed through X-ray equipment, including X-ray TV systems that combine the industry's smallest size with extensive functionality, new angiography systems equipped with the world's first AI-based image-processing technology, and general radiography systems with power-assist functions.」

    The Company specifically disclosed that new products equipped with AI image processing, power assist and other features contributed to higher revenue from expanded sales of X-ray-related products.
  5. FY2021AdvancedAnnual report

    「The company will expand sales of X-ray TV systems, whose profitability has been improving, through business-strengthening measures including shifting to direct sales in the United States.」

    Regarding the expansion of sales of X-ray TV systems, the disclosure identified the move to direct sales in the United States as a specific sales-organization initiative.
  6. FY2021-Q3RestatedAnnual report

    「Mobile X-ray imaging systems increased, mainly overseas, for diagnosing pneumonia caused by COVID-19. Other models, however, performed poorly as capital investment was postponed or frozen because medical institutions prioritized measures against COVID-19 and their profitability deteriorated.」

    The increase in mobile systems for infectious-disease diagnosis and the continued sluggishness of other models due to postponed or frozen capital investment have continued.
  7. FY2021-Q2RestatedAnnual report

    「Mobile X-ray imaging systems increased, mainly overseas, for diagnosing pneumonia caused by COVID-19. Other models, however, performed poorly as capital investment was postponed or frozen because medical institutions prioritized measures against COVID-19 and their profitability deteriorated.」

    Regarding X-ray-related products, demand for mobile units used in infectious disease diagnosis increased, while other models continued to face difficult conditions as medical institutions postponed or froze capital investment.
  8. FY2021-Q1ReframedAnnual report

    「Mobile X-ray imaging systems expanded mainly overseas for use in diagnosing COVID-19 pneumonia, but other models remained weak as medical institutions focused on countermeasures against COVID-19 and their earnings deteriorated due to the spread of the virus.」

    While the drivers of expanded sales of X-ray-related products shifted from digitalization, new products and projects to demand for overseas mobile equipment for infectious disease diagnosis, other models continued to face difficult conditions due to medical institutions concentrating on countermeasures and deteriorating earnings.
  9. FY2020ReframedAnnual report

    「Sales in this business increased overall, despite lower overseas sales, driven by growth in X-ray diagnostic equipment sales in Japan and expansion of the aftermarket business. The angiography systems business performed well in cardiovascular treatment, as the company worked to build its brand in the minimally invasive treatment field.」

    Growth in Medical Systems sales is being supported by X-ray diagnostic equipment in Japan, the aftermarket business and angiography systems for cardiovascular treatment, while the business mix has shifted to a decline in overseas revenue.
  10. FY2020-Q3ReframedAnnual report

    「In Japan, X-ray TV systems, angiography systems, and X-ray imaging systems for clinics continued to perform well. In North America, however, X-ray imaging systems declined as the impact of demand peaking after digitalization-promoting initiatives continued. In Europe, multipurpose X-ray TV systems and angiography systems declined. In China, X-ray imaging systems declined amid intensified competition from locally manufactured products, in addition to project delays. In other parts of Asia, generic X-ray TV systems and angiography systems grew in India, but X-ray imaging systems declined in Southeast Asia, partly due to the reaction to large projects in the previous year.」

    While the theme of expanding sales of X-ray-related products continues, the description has changed by region, with declines attributed to demand running its course, project delays, competition and the absence of large projects in North America, Europe, China and Southeast Asia, in contrast to strong performance in Japan.
  11. FY2020-Q2ReframedAnnual report

    「In North America, X-ray imaging systems declined as the impact of demand reaching a peak following measures to promote digitalization continued. In Europe, multi-purpose X-ray TV systems and angiography systems declined. In China, X-ray imaging systems declined due to intensified competition from domestically produced products, in addition to project delays. In other parts of Asia, angiography systems grew in India, but X-ray TV systems declined substantially in Southeast Asia, partly due to a reactionary decline following large projects in the previous year. In Japan, meanwhile, X-ray TV systems, angiography systems and X-ray imaging systems for clinics performed well, partly due to increased demand ahead of the consumption tax increase.」

    Sales trends for X-ray-related products changed by region: Japan performed well on demand ahead of a tax increase, while demand declined in North America, Europe, China, and Southeast Asia due to demand peaking, competition, project delays, and the reaction to large projects.
  12. FY2020-Q1ReframedAnnual report

    「In Japan, sales increased as angiography systems and X-ray radiography systems performed well. In North America and Europe, however, conditions remained difficult as demand for mobile units declined and multipurpose X-ray TV systems remained sluggish. In China, overall sales declined because sales of X-ray radiography systems fell amid intensifying competition with domestically manufactured products, compounded by project delays. In Southeast Asia, X-ray TV systems declined sharply, partly because of a reaction to the large projects recorded the previous year.」

    While the theme of expanding sales of X-ray-related products continues, the disclosure cites declining demand, competition, project delays, and the reversal of large projects in North America, Europe, China, and Southeast Asia, in contrast to strong performance in Japan, changing the regional mix.
  13. FY2019-Q3RestatedAnnual report

    「In North America, sales of X-ray radiography systems declined as demand generated by measures to promote digitalization in the previous fiscal year leveled off. In Europe, X-ray radiography systems performed well, helped by the popularity of new mobile systems with excellent operability. X-ray TV systems and angiography systems also performed well. In China, overall sales declined because X-ray radiography systems were affected by policies favoring domestic products, while projects for angiography systems were delayed. In Southeast Asia, angiography systems performed well, supported in part by large projects. In Japan, new angiography systems offering reduced radiation exposure, high image quality, improved operability and greater examination efficiency remained firm, while X-ray radiography systems for clinics also performed well.」

    The continued expansion of sales of X-ray radiography, X-ray TV, and angiography systems by region is repeatedly reported, with factors including new products, large projects, and demand from clinics cited. In North America, demand generated by measures taken in the previous fiscal year has settled down, while in China the impact of competition policy and project delays is noted.
  14. FY2019-Q2RestatedAnnual report

    「In North America, multifunctional X-ray TV systems performed well. In Europe, a new mobile system with excellent operability was well received, and X-ray imaging systems performed well. In China, overall sales declined because X-ray imaging systems decreased due to preferential policies for domestic products, while projects involving X-ray TV systems were delayed. In Southeast Asia, X-ray TV systems performed well, supported in part by large projects. In Japan, new angiography systems offering reduced radiation exposure, high image quality, improved operability and greater examination efficiency performed well, while X-ray imaging systems for clinics also remained solid.」

    Sales trends for X-ray imaging and X-ray TV systems and other products continue to be reported by region, with factors including new products, large-scale projects and demand from clinics identified.
  15. FY2019-Q1RestatedAnnual report

    「X-ray TV systems performed well in Southeast Asia, including several large projects.」

    Sales expansion of X-ray TV systems and other products has continued, supported by large-scale projects in Southeast Asia and elsewhere.
  16. FY2018-Q2RestatedAnnual report

    「In North America, X-ray imaging systems grew as the company benefited from the tailwind of digitalization promoted by revisions to medical reimbursement rates. In China, X-ray imaging systems remained firm as demand recovered and the product lineup was strengthened to address customer needs. In Southeast Asia, X-ray imaging systems incorporating demand for digitalization and enhanced angiography systems performed well. In Japan, X-ray imaging systems expanded, including in clinics, and performed well.」

    Sales expansion of X-ray imaging systems and other products has continued. Regional factors cited include capturing demand for digitalization, strengthening the product lineup to meet customer needs and rolling out enhanced models.
  17. FY2018-Q1ReframedAnnual report

    「In Japan, X-ray radiography systems expanded, mainly at clinics, and performed well. In North America, X-ray radiography systems grew significantly and sales increased as the business captured the tailwind from digitalization promoted by revisions to medical reimbursement rates. In Southeast Asia, X-ray radiography systems also grew and sales increased by meeting demand for digitalization.」

    The focus on expanding sales of X-ray products has continued, but the factors cited have shifted from rapid compliance with standards to capturing demand arising from medical fee revisions and digitalization.
  18. FY2017-Q3DroppedAnnual report

    「In Japan, sales of X-ray diagnostic equipment increased, led by X-ray TV systems and angiography systems.」

    Although higher medical equipment revenue is disclosed, the measures explicitly mentioned in the previous quarter, such as rapid compliance with standards and expanded sales targeting the clinic market, are not included.
  19. FY2017-Q2First statedAnnual report

    「Rapid compliance with standards proved effective, driving higher sales of X-ray TV systems and general radiography systems for the clinic market.」

    First appearance of the initiative and results of expanding clinic-market sales through rapid compliance with standards.
Moved together

"Lower Revenue and Operating Profit but Higher Ordinary Profit and Net Income amid the Stronger Yen" moved the same way as this thread, in the same document, in 10 of its 19 moves.

1086555★123456
  1. ★This thread
  2. 1Lower Revenue and Operating Profit but Higher Ordinary Profit and Net Income amid the Stronger Yen10×
  3. 2Revenue and profit growth in the measuring instruments business8×
  4. 3Demand for measuring instruments driven by pharmaceutical, food safety, and transportation equipment projects6×
  5. 4Strengthening the earnings base through expansion of turbomolecular pumps and overseas expansion of hydraulic equipment5×
  6. 5Growing Demand for High-End X-Ray TV and Angiography Systems5×
  7. 6Firm Hydraulic-Equipment Demand Driven by Growth in China’s Forklift and Construction-Machinery Markets5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Shimadzu yet.
Expanding sales of X-ray products for the clinic market through rapid compliance with standards | Shimadzu Corporation (7701) | Komori